Evidence map›Paper›PMID 19513023›Full record

ArticleThe American journal of gastroenterology2009

Phenotypic and genotypic characteristics of inflammatory bowel disease in French Canadians: comparison with a large North American repository.

Mamatha Bhat, Geoffrey C Nguyen, Pierre Pare, Raymond Lahaie, Colette Deslandres, Edmond-Jean Bernard, Guy Aumais, Gilles Jobin, Gary Wild, Albert Cohen and 16 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in The American journal of gastroenterology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Integrated genomic analysis suggests MLL3 is a novel candidate susceptibility gene for familial nasopharyngeal carcinoma.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2015
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

26 authors at 14 institutions in 3 countries.

Mamatha BhatDivision of Gastroenterology, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada. mamatha.bhat@mail.mcgill.ca
Geoffrey C Nguyen
Pierre Pare
Raymond Lahaie
Colette Deslandres
Edmond-Jean Bernard
Guy Aumais
Gilles Jobin
Gary Wild
Albert Cohen
Diane Langelier
Steven Brant
Themistocles Dassopoulos
Dermot McGovern
Esther Torres
Richard Duerr
Miguel Regueiro
Mark S Silverberg
Hillary Steinhart
Anne M Griffiths
Abdul Elkadri
Judy Cho
Deborah Proctor
Philippe Goyette
John Rioux
Alain Bitton
McGill University · CARoyal Victoria Hospital · CAUniversity of Toronto · CAHôpital du Saint-Sacrement · CAHôpital Maisonneuve-Rosemont · CAJohns Hopkins University · USMount Sinai Hospital · CAUniversité de Montréal · CACedars-Sinai Medical Center · USCentre Hospitalier Universitaire Sainte-Justine · CAHôtel-Dieu de Montréal · CAJewish General Hospital · CAUniversity of Pittsburgh · USYale University · US

Funding

YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
ZINC AND CA EDTA THERAPY OF PLUMBISMM01RR000052 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FLEXNER, CHARLES W. · 1985 to 2007
$37.3M
Inflammatory Bowel Disease Genetics Consortium Data Coordinating CenterU01DK062429 · NIDDK · YALE UNIVERSITY · PI CHO, JUDY H. · 2002 to 2016
$16.8M
Precision IBD via genetics and genomics: integrating International and multi-omic datasets, expanding studies in diverse populations, and defining mechanisms of unmet clinical needs in IBDU24DK062429 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ling-shiang Chuang, Ron Do · 2017 to 2026
$13.9M
Utilizing the Phenomics of IBD to Enhance Gene DiscoveryU01DK062413 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI Dermot Patrick McGovern · 2002 to 2026
$12.2M
VALIDATION OF THE CLINICAL DEMENTIA RATING SCALEP20RR011126 · NCRR · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI KRAISELBURD, EDMUNDO NELSON · 1995 to 2009
$11.2M
Yale University Inflammatory Bowel Disease Genetics Research CenterU01DK062422 · NIDDK · YALE UNIVERSITY · PI Ling-shiang Chuang · 2002 to 2026
$10.8M
IBD Gene Mapping by Clinical and Population SubsetsU01DK062431 · NIDDK · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Steven R Brant · 2002 to 2026
$10.7M
Universite de Montreal IBD Genetics Research CenterU01DK062432 · NIDDK · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI John D. Rioux · 2002 to 2026
$9.6M
NIDDK IBD Genetics Consortium Genetic Research CenterU01DK062420 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DUERR, RICHARD H · 2002 to 2021
$7.8M
Identification of the IBD genes on chromosomes 3p and 6pR01DK064869 · NIDDK · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI RIOUX, JOHN D. · 2003 to 2016
$7.8M
Impact of Genetic Variability on Cellular Pathways and Host-Microbiome InteractioU01DK062423 · NIDDK · SINAI HEALTH SYSTEM · PI MARK S. SILVERBERG · 2002 to 2026
$7.5M
NCRR NIH HHS 5P20RR011126NCRR NIH HHS M01 RR000052NCRR NIH HHS P20 RR011126NCRR NIH HHS RR00052NCRR NIH HHS RR024139NCRR NIH HHS UL1 RR024139NIDDK NIH HHS DK062413NIDDK NIH HHS DK062420NIDDK NIH HHS DK062422NIDDK NIH HHS DK062423NIDDK NIH HHS DK062429NIDDK NIH HHS DK062431NIDDK NIH HHS DK062432NIDDK NIH HHS DK064869NIDDK NIH HHS DK072373NIDDK NIH HHS DK076025NIDDK NIH HHS R01 DK064869NIDDK NIH HHS R01 DK072373NIDDK NIH HHS R01 DK076025NIDDK NIH HHS U01 DK062413NIDDK NIH HHS U01 DK062420NIDDK NIH HHS U01 DK062422NIDDK NIH HHS U01 DK062423NIDDK NIH HHS U01 DK062429NIDDK NIH HHS U01 DK062431NIDDK NIH HHS U01 DK062432NIDDK NIH HHS U24 DK062429NIMH NIH HHS MH057881NIMH NIH HHS R01 MH057881NIMH NIH HHS R37 MH057881
6 · The paper itself

Abstract

objectivesPhenotype characteristics of inflammatory bowel disease (IBD) may differ significantly among ethnic subpopulations. The aim of this study was to characterize the IBD phenotype in French Canadians, the most prominent founder population in North America.

methodsUsing well-characterized phenotype data in the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)-IBD Genetics Consortium repository on patients with IBD, we compared phenotypic characteristics of 202 French Canadians with those of 1,287 other Caucasian patients. These included diagnosis, anatomical location, disease behavior, extraintestinal manifestations, surgical history, and family history of IBD.

resultsFrench-Canadian patients with Crohn's disease (CD) were less likely to have stricturing disease (11 vs. 21%, P=0.005; odds ratio (OR): 0.45, 95% confidence interval (95% CI): 0.24-0.85). Using a stringent definition of ethnicity (three out of four grandparents being French Canadians, as opposed to self-report, n=148), French Canadians had a tendency toward developing fistulizing CD (37 vs. 28%, P=0.07), and there was an increased prevalence of sacroiliitis among those with IBD (4 vs. 2%, P=0.045). Among French Canadians, the numbers of current smokers in CD (40 vs. 25%, P=0.006) and former smokers in ulcerative colitis (UC) (35 vs. 20%, P=0.03) were significantly higher. The prevalence of one of the three main variants of nucleotide-binding oligomerization domain containing 2 (NOD2) single-nucleotide polymorphisms (SNPs) among French-Canadian CD patients was 43.2%. The 3020insC SNP correlated with small bowel disease in French Canadians (25 [corrected] vs. 0%, P=0.006).

conclusionsFrench Canadians show an IBD phenotype profile distinct from other Caucasian IBD populations, with an accentuated association between smoking status and IBD. This unique profile may have implications regarding the need for a different approach to the management of IBD in this population.

Indexed as

AdultCanadaFemaleFounder EffectFranceGenotypeHumansInflammatory Bowel DiseasesMaleMiddle AgedNorth AmericaPhenotypeUnited StatesYoung Adult

Identifiers

PMID19513023
PMCPMC2742627
OpenAlexW1966033150

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.